ArticleNPJ breast cancer2021

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection.

Alexa C Glencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.